Black Rock Inc. Nu Cana PLC Transaction History

Black Rock Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$2.02 - $2.9 $479,263 - $688,051	-237,259 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$1.95 - $2.85 $8,162 - $11,930	-4,186 Reduced 1.73%	237,259 $612,000
Q2 2021 Aug 11, 2021	BUY	$2.7 - $5.04 $651,901 - $1.22 Million	241,445 New	241,445 $669,000

3.33M

Ticker NCNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,196,000
Market Cap $66.3M
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.